fulvestrant has been researched along with Allergic Encephalomyelitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, J; Chen, Y; Dai, Y; Hu, X; Li, R; Lu, Z; Qiu, W; Shu, Y; Wu, A; Xu, W | 1 |
| Ahlem, C; Auci, D; Frincke, J; Mangano, K; Nicoletti, F; Reading, C; Stickney, D | 1 |
| Adelman, SJ; Elloso, MM; Harris, HA; Henderson, RA; Phiel, K | 1 |
3 other study(ies) available for fulvestrant and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Raloxifene suppresses experimental autoimmune encephalomyelitis and NF-κB-dependent CCL20 expression in reactive astrocytes.
Topics: Animals; Astrocytes; Cell Movement; Cells, Cultured; Chemokine CCL20; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Estradiol; Female; Fulvestrant; Gene Expression Regulation; Mice; Mice, Inbred C57BL; Multiple Sclerosis; NF-kappa B; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Signal Transduction; Th17 Cells | 2014 |
HE3286: a novel synthetic steroid as an oral treatment for autoimmune disease.
Topics: Administration, Oral; Androstenols; Animals; Autoimmune Diseases; Clinical Trials as Topic; Colitis, Ulcerative; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Male; Mice; Mice, Inbred Strains; Rats; Rats, Wistar; Treatment Outcome | 2009 |
Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands.
Topics: Adoptive Transfer; Animals; Cell Proliferation; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Flow Cytometry; Fulvestrant; Mice; Mice, Inbred Strains; Ovariectomy; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; T-Lymphocytes, Regulatory | 2005 |